vVARDIS Holding AG Completes Initial Public Offering on the NYSE

Swiss dental medtech company vVARDIS Holding AG began trading on the NYSE under ticker VVVV on November 13, 2026. It priced its IPO at $18 per share for 9.72 million Class A ordinary shares, raising approximately $175 million in gross proceeds. Underwriters have a 30-day option to buy up to 1.46 million additional shares. The company’s Curodont platform uses guided enamel remineralization to treat early-stage tooth decay.